Carregant...
Optimizing antiviral agents for hepatitis B management in malignant lymphomas
The global scale of hepatitis B infection is well known but its impact is still being understood. Missed hepatitis B infection impacts lymphoma therapy especially increased risk of hepatitis B virus (HBV) reactivation and poor treatment outcomes. The presence of undiagnosed chronic hepatitis also un...
Guardat en:
| Publicat a: | Ann Transl Med |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
AME Publishing Company
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5326643/ https://ncbi.nlm.nih.gov/pubmed/28251118 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2016.12.25 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|